Aripiprazole

Generic Details

Generic Name

Aripiprazole

Other Names

  • Abilify

Drug Class

  • Atypical Antipsychotic

Chemical Formula

C23H27Cl2N3O2

Molecular Weight

448.38 g/mol

Mechanism of Action

  • Partial agonist at dopamine D2 and serotonin 5-HT1A receptors; antagonist at serotonin 5-HT2A receptor

Indications

  • Schizophrenia
  • Bipolar disorder
  • Major depressive disorder
  • Autism spectrum disorder
  • Tourette's disorder
  • Irritability associated with autistic disorder
  • Agitation associated with schizophrenia or bipolar disorder

Common Dosage Forms

  • Tablet
  • Oral solution

Typical Dosage

  • 10-15 mg once daily for schizophrenia
  • 5-10 mg once daily for bipolar disorder
  • 2-5 mg once daily for major depressive disorder

Pediatric Dosage

  • Dosage adjustments may be required based on weight and condition

Geriatric Dosage

  • Lower starting doses may be needed in the elderly

Side Effects

  • Drowsiness
  • Headache
  • Nervousness
  • Insomnia
  • Constipation
  • Weight gain
  • Tremor

Contraindications

  • Hypersensitivity to aripiprazole
  • Severe cardiac disorders

Pregnancy Category

  • C - Risk cannot be ruled out

Lactation Safety

  • Limited data available; use with caution

Drug Interactions

  • Antidepressants
  • Antifungals
  • Antipsychotics
  • Benzodiazepines
  • Beta blockers

Overdose Symptoms

  • Extreme drowsiness
  • Uncontrolled muscle movements
  • Agitation

Antidote for Overdose

  • There is no specific antidote; treatment is supportive

Storage Conditions

  • Store at room temperature away from moisture and heat

Pharmacokinetics

  • Absorption: Well-absorbed orally, peak plasma levels in 3-5 hours
  • Distribution: Crosses the blood-brain barrier and placenta, enters breast milk
  • Metabolism: Primarily hepatic via CYP2D6 and CYP3A4 enzymes
  • Excretion: Mainly via feces (55%) and urine (45%)

Precautions

  • Increased risk of suicidal thoughts in children, adolescents, and young adults
  • Caution in patients with a history of seizures or neuroleptic malignant syndrome

Warnings

  • Increased mortality in elderly patients with dementia-related psychosis